Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 10 04:00PM ET
17.00
Dollar change
-0.20
Percentage change
-1.16
%
Index- P/E- EPS (ttm)-2.64 Insider Own0.88% Shs Outstand492.85M Perf Week25.65%
Market Cap8.40B Forward P/E15.99 EPS next Y1.06 Insider Trans0.88% Shs Float489.73M Perf Month15.25%
Income-1302.00M PEG- EPS next Q0.23 Inst Own97.59% Short Float2.75% Perf Quarter6.45%
Sales4.37B P/S1.92 EPS this Y4.86% Inst Trans-3.01% Short Ratio3.06 Perf Half Y56.68%
Book/sh12.26 P/B1.39 EPS next Y13.91% ROA-8.74% Short Interest13.47M Perf Year88.89%
Cash/sh0.70 P/C24.35 EPS next 5Y8.87% ROE-19.24% 52W Range7.88 - 17.43 Perf YTD14.09%
Dividend Est.- P/FCF30.66 EPS past 5Y- ROI-11.05% 52W High-2.47% Beta1.43
Dividend TTM- Quick Ratio1.96 Sales past 5Y9.00% Gross Margin42.75% 52W Low115.74% ATR (14)0.70
Dividend Ex-Date- Current Ratio3.29 EPS Y/Y TTM-5619.91% Oper. Margin5.45% RSI (14)71.37 Volatility5.60% 4.24%
Employees9800 Debt/Eq0.95 Sales Y/Y TTM-1.91% Profit Margin-29.83% Recom2.00 Target Price19.00
Option/ShortYes / Yes LT Debt/Eq0.95 EPS Q/Q-69.14% Payout- Rel Volume0.84 Prev Close17.20
Sales Surprise1.45% EPS Surprise24.09% Sales Q/Q-4.14% EarningsMay 08 BMO Avg Volume4.40M Price17.00
SMA2023.39% SMA5013.35% SMA20028.93% Trades Volume3,689,936 Change-1.16%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Jul-21-22Downgrade Goldman Buy → Sell $32 → $19
Jul-12-22Initiated Piper Sandler Neutral $22
Nov-18-21Initiated Morgan Stanley Overweight $40
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM Loading…
03:05AM
May-08-24 04:04PM
02:00PM
12:32PM
09:30AM
09:18AM
07:52AM
07:25AM
06:28AM
May-06-24 09:15AM
11:27AM Loading…
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
06:30AM
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM Loading…
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
Feb-07-24 01:25PM
Feb-05-24 07:01AM
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Jan-01-24 09:15AM
Dec-19-23 08:00AM
Dec-14-23 05:08PM
Dec-08-23 09:00AM
Dec-07-23 04:37PM
Nov-27-23 08:00AM
Nov-10-23 05:20PM
Nov-09-23 03:49AM
Nov-08-23 04:03PM
12:21AM
Nov-07-23 01:45PM
09:30AM
07:31AM
07:03AM
06:33AM
Nov-02-23 11:33AM
08:00AM
07:16AM
Nov-01-23 09:00AM
Oct-30-23 04:32PM
Oct-17-23 04:57PM
08:00AM
Oct-09-23 09:55AM
Oct-06-23 12:05PM
08:36AM
Oct-05-23 11:22AM
Oct-04-23 06:30AM
Sep-19-23 06:20AM
04:23AM
Sep-12-23 06:40AM
Sep-07-23 04:15PM
Sep-05-23 05:00PM
Aug-09-23 10:36AM
07:56AM
Aug-08-23 12:16AM
Aug-07-23 02:30PM
12:34PM
09:30AM
07:50AM
06:33AM
Aug-02-23 07:10AM
06:55AM
Jul-20-23 08:00AM
Jul-18-23 08:00AM
Jul-17-23 08:48AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM